BlueWillow is a biopharmaceutical company that develops and commercializes intranasal vaccines for infectious and allergic diseases. Read more

6 Followers on Owler
6 Followers on Owler
6 Followers on Owler
6 Followers on Owler

BlueWillow is a biopharmaceutical company that develops and commercializes intranasal vaccines for infectious and allergic diseases. Read more

David Peralta's photo - CEO of BlueWillow Biologics

CEO

David Peralta

CEO Approval Rating

87/100

Founded:

2006

Status:

PrivateIndependent Company

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

VBI Vaccines is one of BlueWillow Biologics's top competitors. VBI Vaccines is a Public company that was founded in Cambridge, Massachusetts in 2001. VBI Vaccines is in the Pharmaceuticals field. VBI Vaccines has 98 more employees vs. BlueWillow Biologics.

Microbiotix, Inc. is perceived as one of BlueWillow Biologics's biggest rivals. Microbiotix, Inc. was founded in 1998 in Worcester, Massachusetts. Microbiotix, Inc. operates in the Pharmaceuticals industry. Microbiotix, Inc. generates $500K less revenue than BlueWillow Biologics.

Nanospectra is a top competitor of BlueWillow Biologics. Nanospectra's headquarters is in Houston, Texas, and was founded in 2001. Nanospectra competes in the Health Care Technology field. Nanospectra generates 50% of BlueWillow Biologics's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 25 a good estimate for BlueWillow Biologics's Employee count?

Acquisitions

No recent acquisitions found related to BlueWillow Biologics

BlueWillow Biologics Funding History

$10M$11.8M$12.6M$22.6M$23.4M$31.6M

Since BlueWillow Biologics was founded in 2006, it has participated in 6 rounds of funding. In total BlueWillow Biologics has raised $31.6M. BlueWillow Biologics' last funding round was on Mar 2020 for a total of $8.2M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Mar 2020
$8.2M

North Coast Technology Investors

Debt
Aug 2019
$800K
-
Series A
May 2018
$10M
Debt
Jan 2017
$775K
-
Convertible Note
Dec 2015
$1.8M
-

Since BlueWillow Biologics was founded in 2006, it has participated in 6 rounds of funding. In total BlueWillow Biologics has raised $31.6M. BlueWillow Biologics' last funding round was on Mar 2020 for a total of $8.2M

Investments

No recent investments found related to BlueWillow Biologics

BlueWillow Biologics News

May 12, 2020St Louis Post Dispatch

Michigan company says its nasal antiseptic can kill coronavirus

DETROIT - With the blessing of British scientists, a Michigan bio-pharmaceutical company is hitting t... See more »
May 6, 2020MarketScreener

NanoBio Protect Over-The-Counter Nasal Antiseptic Kills COVID-19 Virus in Lab Tests

(marketscreener.com) ANN ARBOR, Mich., May 6, 2020 /PRNewswire/ -- BlueWillow Biologics® today announ... See more »
April 3, 2020DBusiness Magazine

Ann Arbor's BlueWillow Develops Nasal Antiseptic in Face of COVID-19

BlueWillow Biologics, a clinical-stage biopharmaceutical company in Ann Arbor, is advancing the manuf... See more »
January 7, 2020BioPortfolio

Intranasal Anthrax Vaccine Candidate Off to the Races

BlueWillow Biologics this month plans to vaccinate its first patients with a nextgeneration anthrax v... See more »
October 25, 2019Pharmabiz

BlueWillow gets US FDA clearance to initiate phase 1 study of intranasal anthrax vaccine, BW─1010

BlueWillow Biologics, a clinical─stage biopharmaceutical company, announced the US Food and Drug Admi... See more »

BlueWillow Biologics Press Releases

August 6, 2019PR Newswire

BlueWillow Biologics Named to Crain's 'Cool Places to Work in Michigan'

ANN ARBOR, Mich., Aug. 6, 2019 /PRNewswire/ -- BlueWillow Biologics® today announced the company has ... See more »
September 26, 2018PR Newswire

BlueWillow Biologics Awarded Grant for Chlamydia Vaccine Development

ANN ARBOR, Mich., Sept. 26, 2018 /PRNewswire/ -- BlueWillow Biologics® today announced the company ha... See more »
May 30, 2018ForImmediateRelease

BlueWillow Biologics Announces Issuance of Therapeutic Cancer Vaccine Patent

Travel & Tourism Industry release: ANN ARBOR, Mich., May 30, 2018 /PRNewswire/ - BlueWillow Biologics... See more »
January 30, 2017https://www.sec.gov

Received $775K in Debt Funding

July 19, 2016Business Wire

Burkholderia Infections - Pipeline Review, H1 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Burkholderia Infecti... See more »
May 10, 2016Business Wire

Actelion, Microbion Corp, Verona Pharma - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Cystic Fibrosis - Pi... See more »

Social Media

Headquarters

2311 Green Road

Ann Arbor, Michigan48105

734-302-4000

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

BlueWillow is a biopharmaceutical company that develops and commercializes intranasal vaccines for infectious and allergic diseases. BlueWillow Biologics was founded in 2006. BlueWillow Biologics' headquarters is located in Ann Arbor, Michigan, USA 48...

CEO

BlueWillow Biologics's CEO, David Peralta, currently has an approval rating of 87%. BlueWillow Biologics's primary competitors are VBI Vaccines, Microbiotix, Inc. & Nanospectra.

Website

bluewillow.com

Frequently Asked Questions about BlueWillow Biologics

  1. When was BlueWillow Biologics founded?

    BlueWillow Biologics was founded in 2006
  2. Who is BlueWillow Biologics's CEO?

    BlueWillow Biologics's CEO is David Peralta
  3. How much revenue does BlueWillow Biologics generate?

    BlueWillow Biologics generates $10M in revenue
  4. How much funding does BlueWillow Biologics have?

    BlueWillow Biologics has historically raised $31.6M in funding
  1. Where is BlueWillow Biologics's headquarters?

    BlueWillow Biologics's headquarters is in Ann Arbor Michigan, USA
  2. How many employees does BlueWillow Biologics have?

    BlueWillow Biologics has 25 employees
  3. What sector does BlueWillow Biologics operate in?

    BlueWillow Biologics is in Biotechnology
  4. Who are BlueWillow Biologics's competitors?

    BlueWillow Biologics's top competitors are VBI Vaccines, Microbiotix, Inc., Nanospectra